Molecular Diagnostics
Molecular Profiling Identifies High-Risk Subtype of Pediatric Liver Cancer
Hepatoblastoma (HB) and hepatocellular carcinoma (HCC) are the most common primary liver malignancies in children, adolescents, and young adults. HB is usually diagnosed in young children and has shown an unequivocal rise in incidence, representing the pediatric cancer with the highest average annual percent increase in incidence over the past three decades. More...01 Jun 2022
Roche Develops Monkeypox Virus Detection PCR Tests
In response to the recent monkeypox virus concerns, Roche Diagnostics (Basel, Switzerland) and its subsidiary TIB Molbiol (Berlin, Germany) have developed three unique LightMix Modular Virus kits for the detection of the monkeypox virus. More...31 May 2022
POC Critical Illness Test Designed for Early Warning and Patient Triaging
An easy-to-use, quantitative test for early warning and patient triaging measures levels of the prognostic biomarker suPAR to allow clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression and outcome. More...31 May 2022
Tear Fluid Collected Using Noninvasive Technique Could Help Diagnose Diseases
Researchers have found that the same tissue paper, called a Schirmer strip, already placed painlessly against the eye to measure tear production in patients, can also capture a sufficient volume of tear fluid for a detailed protein analysis. More...30 May 2022
Illumina’s Pan-Cancer Companion Diagnostic Enables Targeted Therapy
Most companion diagnostic (CDx) tests are specific to one type of cancer, but a new CDx test allows for identification of cancer patients with solid tumors who are positive for neurotrophic tyrosine receptor kinase (NTRK) gene fusions, including NTRK1, NTRK2 or NTRK3. More...30 May 2022
New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Electrolyte Analyzer
BKE-B
New
Urine Analyzer
respons® UDS100
In Other News
POC System Could Transform Infectious Disease Management
mRNA Test Screens for Multiple Cancers from Single Blood Sample
A Circulating Antibody Enables Prediction of Crohn’s Disease Long Before Symptoms Appear
Bioperfectus Monkeypox Virus Real Time PCR Kit Receives CE Mark
Blood Test Detects Markers for Liver Injury from Acetaminophen Overdose in 20 Minutes
Next-Generation Sequencing Enables Diagnosis of Primary Immunodeficiency Disorders
Clinical Multiplex Benchtop Diagnostic System Runs Tests Directly From Whole Blood
Blood Test Predicts Response to Immunotherapy in Patients with Non-Small Cell Lung Cancer
ALL Genomes Marked by High DNA Methylation Levels
Circulating Tumor DNA Test Clinically Validated
High-Resolution Mass Spectrometry-Based Test Diagnoses Alzheimer’s Disease
Multiplex PCR-Based Test Detects UTI Pathogens and Antimicrobial Resistance Genes
Biomarker Based Non-Endoscopic Technology Identifies Risk for Esophageal Cancer
Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis
Revolutionary Blood Test to Transform Early Diagnosis of Bowel Cancer
Mass Spectrometry Could Enable Early Prediction of Alzheimer’s Disease from Blood Samples
Study Identifies Molecular Signatures in Arthritis Patients for Incorporation In Diagnostic Tests
Biosensor Technology Could Pave Way for POC Diagnosis of Cancer, Pathogens, and Other Diseases
Nasal Swab Test Accurately Assesses Lung Cancer Risk Among Smokers with Lung Nodules
Qiagen Launches RT qPCR Test for Sensitive Detection of EGFR Mutations to Guide NSCLC Treatment
Minimally Invasive Device Combined With Molecular Biomarkers Detects Early Esophageal Cancer
Rapid Result Test for Complicated Urinary Tract Infections Proves Superior to Standard Urine Culture
First Fully Automated, Standardized Pre-Analytical Platform for Comprehensive Liquid Biopsy Testing
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.